| From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics SG Wicha, AG Märtson, EI Nielsen, BCP Koch, LE Friberg, JW Alffenaar, ... Clinical Pharmacology & Therapeutics 109 (4), 928-941, 2021 | 155 | 2021 |
| Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid … CWM Ong, GB Migliori, M Raviglione, G MacGregor-Skinner, G Sotgiu, ... European Respiratory Journal 56 (4), 2020 | 151 | 2020 |
| Population pharmacokinetics and Bayesian dose adjustment to advance TDM of anti-TB drugs MGG Sturkenboom, AG Märtson, EM Svensson, DJ Sloan, KE Dooley, ... Clinical pharmacokinetics 60, 685-710, 2021 | 63 | 2021 |
| Clinical standards for the dosing and management of TB drugs JWC Alffenaar, SL Stocker, LD Forsman, A Garcia-Prats, SK Heysell, ... The International Journal of Tuberculosis and Lung Disease 26 (6), 483-499, 2022 | 51 | 2022 |
| Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems AG Märtson, G Burch, S Ghimire, JWC Alffenaar, CA Peloquin Expert Opinion on Drug Metabolism & Toxicology 17 (1), 23-39, 2021 | 41 | 2021 |
| How to design a study to evaluate therapeutic drug monitoring in infectious diseases? AG Märtson, MGG Sturkenboom, J Stojanova, D Cattaneo, W Hope, ... Clinical Microbiology and Infection 26 (8), 1008-1016, 2020 | 41 | 2020 |
| Clinical standards for drug-susceptible pulmonary TB OW Akkerman, R Duarte, S Tiberi, HS Schaaf, C Lange, JWC Alffenaar, ... The International Journal of Tuberculosis and Lung Disease 26 (7), 592-604, 2022 | 31 | 2022 |
| Ganciclovir therapeutic drug monitoring in transplant recipients AG Märtson, AE Edwina, JGM Burgerhof, SP Berger, A de Joode, ... Journal of Antimicrobial Chemotherapy 76 (9), 2356-2363, 2021 | 29 | 2021 |
| Therapeutic drug monitoring of ganciclovir: where are we? AG Märtson, AE Edwina, HY Kim, M Knoester, DJ Touw, ... Therapeutic Drug Monitoring 44 (1), 138-147, 2022 | 27 | 2022 |
| Therapeutic drug monitoring in non-tuberculosis mycobacteria infections JW Alffenaar, AG Märtson, SK Heysell, JG Cho, A Patanwala, G Burch, ... Clinical Pharmacokinetics 60, 711-725, 2021 | 27 | 2021 |
| Coronavirus disease-19: an interim evidence synthesis of the world association for infectious diseases and immunological disorders (Waidid) B Abu-Raya, GB Migliori, M O'Ryan, K Edwards, A Torres, JW Alffenaar, ... Frontiers in medicine 7, 572485, 2020 | 26 | 2020 |
| Optimization of fluconazole dosing for the prevention and treatment of invasive candidiasis based on the pharmacokinetics of fluconazole in critically ill patients JM Boonstra, AG Märtson, I Sandaradura, JGW Kosterink, ... Antimicrobial Agents and Chemotherapy 65 (3), 10.1128/aac. 01554-20, 2021 | 21 | 2021 |
| Ganciclovir Therapeutic Drug Monitoring: A Case Series AG Märtson, D Touw, K Damman, M Bakker, AO Lansink-Hartgring, ... Therapeutic drug monitoring 41 (2), 107-110, 2019 | 21 | 2019 |
| Caspofungin weight-based dosing supported by a population pharmacokinetic model in critically ill patients AG Märtson, KCM van der Elst, A Veringa, JG Zijlstra, A Beishuizen, ... Antimicrobial Agents and Chemotherapy 64 (9), 10.1128/aac. 00905-20, 2020 | 20 | 2020 |
| Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations AG Märtson, A Veringa, ER van den Heuvel, M Bakker, DJ Touw, ... Mycoses 62 (8), 698-705, 2019 | 19 | 2019 |
| Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the … HY Kim, S Baldelli, AG Märtson, S Stocker, JW Alffenaar, D Cattaneo, ... Therapeutic drug monitoring 44 (1), 198-214, 2022 | 18 | 2022 |
| Determination of Ganciclovir and Acyclovir in Human Serum using Liquid Chromatogra-phy-Tandem Mass Spectrometry A Märtson, K van Hateren, G van den Bosch, T van der Werf, D Touw, ... J Appl Bioanal 4 (5), 175-186, 2018 | 17 | 2018 |
| Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review. HY Kim, AG Märtson, E Dreesen, I Spriet, SG Wicha, AJ McLachlan, ... Frontiers in Pharmacology 11, 894, 2020 | 14 | 2020 |
| Therapeutic Drug Monitoring of Anti-infective Drugs: Implementation Strategies for 3 Different Scenarios. HY Kim, KC Byashalira, SK Heysell, AG Märtson, SG Mpagama, P Rao, ... Therapeutic Drug Monitoring 44 (1), 3-10, 2022 | 12 | 2022 |
| Posaconazole trough concentrations are not influenced by inflammation: A prospective study AG Märtson, A Veringa, M Bakker, ER van den Heuvel, DJ Touw, ... International journal of antimicrobial agents 53 (3), 325-329, 2019 | 12 | 2019 |
